309 related articles for article (PubMed ID: 28425681)
41. Enantiospecific Synthesis, Chiral Separation, and Biological Activity of Four Indazole-3-Carboxamide-Type Synthetic Cannabinoid Receptor Agonists and Their Detection in Seized Drug Samples.
Antonides LH; Cannaert A; Norman C; Vives L; Harrison A; Costello A; Nic Daeid N; Stove CP; Sutcliffe OB; McKenzie C
Front Chem; 2019; 7():321. PubMed ID: 31157203
[TBL] [Abstract][Full Text] [Related]
42. Schedules of Controlled Substances: Placement of Three Synthetic Phenethylamines Into Schedule I. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2016 Sep; 81(187):66181-4. PubMed ID: 27726316
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and
Cannaert A; Sparkes E; Pike E; Luo JL; Fang A; Kevin RC; Ellison R; Gerona R; Banister SD; Stove CP
ACS Chem Neurosci; 2020 Dec; 11(24):4434-4446. PubMed ID: 33253529
[TBL] [Abstract][Full Text] [Related]
44. [Determination of four amide synthetic cannabinoid isomers by ultra-high performance liquid chromatography-high resolution mass spectrometry].
Tang R; Wang J; Xiao T; Qin S; Jie Z; Zhang A
Se Pu; 2024 Jan; 42(1):84-91. PubMed ID: 38197209
[TBL] [Abstract][Full Text] [Related]
45. Schedules of Controlled Substances: Extension of Temporary Placement of Three Synthetic Phenethylamines in Schedule I. Final order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2015 Nov; 80(219):70657-9. PubMed ID: 26567439
[TBL] [Abstract][Full Text] [Related]
46. Identification and characterization of an indazole-3-carboxamide class synthetic cannabinoid: 2-[1-(cyclohexylmethyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoic acid (DMBA-CHMINACA).
Lee JH; Jung A; Park HN; Lee C; Mandava S; Lim SJ; Lim BB; Park SK; Lee J; Kang H
Forensic Sci Int; 2018 Oct; 291():167-174. PubMed ID: 30216842
[TBL] [Abstract][Full Text] [Related]
47. Schedules of Controlled Substances: Placement of MT-45 Into Schedule I. Final order.
Drug Enforcement Administration, Department of Justice.
Fed Regist; 2017 Dec; 82(238):58557-9. PubMed ID: 29235771
[TBL] [Abstract][Full Text] [Related]
48. Schedules of Controlled Substances: Placement of Eluxadoline Into Schedule IV. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2015 Nov; 80(218):69861-4. PubMed ID: 26567437
[TBL] [Abstract][Full Text] [Related]
49. Schedules of Controlled Substances: Placement of 10 Synthetic Cathinones Into Schedule I. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2017 Mar; 82(39):12171-7. PubMed ID: 28355044
[TBL] [Abstract][Full Text] [Related]
50. Schedules of Controlled Substances: Placement of Butyryl Fentanyl and U–47700 Into Schedule I. Final order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2018 Apr; 83(77):17486-8. PubMed ID: 30016012
[TBL] [Abstract][Full Text] [Related]
51. Schedules of controlled substances: placement of suvorexant into Schedule IV. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2014 Aug; 79(167):51243-7. PubMed ID: 25167596
[TBL] [Abstract][Full Text] [Related]
52. Schedule of controlled substances: placement of tramadol into schedule IV. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2014 Jul; 79(127):37623-30. PubMed ID: 25016619
[TBL] [Abstract][Full Text] [Related]
53. Schedules of controlled substances: placement of perampanel into Schedule III. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2013 Dec; 78(231):72013-6. PubMed ID: 24294637
[TBL] [Abstract][Full Text] [Related]
54. Detection of the Synthetic Cannabinoids AB-CHMINACA, ADB-CHMINACA, MDMB-CHMICA, and 5F-MDMB-PINACA in Biological Matrices: A Systematic Review.
Navarro-Tapia E; Codina J; Villanueva-Blasco VJ; García-Algar Ó; Andreu-Fernández V
Biology (Basel); 2022 May; 11(5):. PubMed ID: 35625524
[TBL] [Abstract][Full Text] [Related]
55. Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry.
Yeter O; Ozturk YE
Drug Test Anal; 2019 Jun; 11(6):847-858. PubMed ID: 30610752
[TBL] [Abstract][Full Text] [Related]
56. Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2011 Oct; 76(204):65371-5. PubMed ID: 22016903
[TBL] [Abstract][Full Text] [Related]
57. Detection and quantification of 5F-ADB and its methyl ester hydrolysis metabolite in fatal intoxication cases by liquid chromatography-high resolution mass spectrometry.
Yeter O; Erol Öztürk Y
Forensic Sci Int; 2019 Sep; 302():109866. PubMed ID: 31302415
[TBL] [Abstract][Full Text] [Related]
58. Induction of Liver Size Reduction in Zebrafish Larvae by the Emerging Synthetic Cannabinoid 4F-MDMB-BINACA and Its Impact on Drug Metabolism.
Park YM; Dahlem C; Meyer MR; Kiemer AK; Müller R; Herrmann J
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209079
[TBL] [Abstract][Full Text] [Related]
59. A Systematic Study of the In Vitro Pharmacokinetics and Estimated Human In Vivo Clearance of Indole and Indazole-3-Carboxamide Synthetic Cannabinoid Receptor Agonists Detected on the Illicit Drug Market.
Brandon AM; Antonides LH; Riley J; Epemolu O; McKeown DA; Read KD; McKenzie C
Molecules; 2021 Mar; 26(5):. PubMed ID: 33807614
[TBL] [Abstract][Full Text] [Related]
60. The synthesis and characterization of the 'research chemical' N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide (3,5-AB-CHMFUPPYCA) and differentiation from its 5,3-regioisomer.
McLaughlin G; Morris N; Kavanagh PV; Power JD; Twamley B; O'Brien J; Talbot B; Dowling G; Brandt SD
Drug Test Anal; 2016 Sep; 8(9):920-9. PubMed ID: 26360802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
